BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen B, Zhang Q, Wang X, Wang Y, Cui J, Zhuang H, Tang J. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma. Aging (Albany NY) 2020;12:3647-61. [PMID: 32090981 DOI: 10.18632/aging.102835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ashrafizadeh M, Rabiee N, Prem Kumar A, Sethi G, Zarrabi A, Wang Y. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. Drug Discov Today 2022:S1359-6446(22)00202-1. [PMID: 35589014 DOI: 10.1016/j.drudis.2022.05.012] [Reference Citation Analysis]
2 Luo C, Lin K, Hu C, Zhu X, Zhu J, Zhu Z. LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Mol Ther Nucleic Acids 2021;26:523-35. [PMID: 34631282 DOI: 10.1016/j.omtn.2021.08.024] [Reference Citation Analysis]
3 Seyed Hosseini E, Nikkhah A, Sotudeh A, Alizadeh Zarei M, Izadpanah F, Nikzad H, Haddad Kashani H. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant). Cancer Cell Int 2021;21:447. [PMID: 34425840 DOI: 10.1186/s12935-021-02125-1] [Reference Citation Analysis]
4 Ghafouri-Fard S, Fathi M, Zhai T, Taheri M, Dong P. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules 2021;11:1665. [PMID: 34827663 DOI: 10.3390/biom11111665] [Reference Citation Analysis]